Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02179944 · ClinicalTrials.gov registry record
Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion
A clinical trial, sponsored by Planned Parenthood League of Massachusetts.
- Completed
- Registry status
- 66
- Enrollment target
NCT02179944 is a clinical trial that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 66 participants.
The verdict
NCT02179944 has completed, sponsored by Planned Parenthood League of Massachusetts.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
This project will be a prospective physiologic study. We will closely follow 60 medication abortion patients with serial repeat serum hCG and urine semi-quantitative hCG testing. We plan to recruit patients from two gestational age strata: ≤ 49 days and \> 49 days. Study Objectives: 1. To create a nomogram describing the change in serum hCG values in the first five days immediately following medication abortion with mifepristone and misoprostol. Specifically, we will describe the percent serum hCG decline from Day 1 (day of mifepristone) to Day 3 (day after misoprostol), from Day 1 to Day 5, and from Day 1 to Day 7-10. 2. To explore whether there is a significant difference in the rate of hCG decline based on initial gestational age determined by ultrasound and initial serum hCG. 3. To describe the correlation between semi-quantitative urine hCG test results and serum hCG values to determine how soon after initiating medication abortion the urine test can detect completed abortion. We hypothesize that among successful medication abortions, there will be a predictable trend with at least a 50% drop by Day 3 and 80% drop by Day 5.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02179944
The ClinicalTrials.gov registry entry for NCT02179944 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02179944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02179944 about?
NCT02179944 is a clinical study titled "Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion". This project will be a prospective physiologic study. We will closely follow 60 medication abortion patients with serial repeat serum hCG and urine semi-quantitative hCG testing. We plan to recruit patients from two gestational age strata: ≤ 49 days and \> 49 days. Study Objectives: 1. To create a...
What is the current status of trial NCT02179944?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2014-07. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02179944?
This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.